Recombinant Human HNF4a Protein，His

HNF4α (Hepatocyte Nuclear Factor 4 Alpha) is a key transcription factor primarily expressed in the liver, pancreas, and intestine, playing a crucial role in regulating metabolic pathways and maintaining glucose homeostasis. Abnormalities in HNF4α expression or function are associated with various metabolic disorders, including maturity-onset diabetes of the young (MODY) and non-alcoholic fatty liver disease (NAFLD). Recent studies have highlighted HNF4α as a critical player in liver development, lipid metabolism, and insulin signaling, thus making it a potential therapeutic target for diabetes and other metabolic diseases. The generation of recombinant HNF4α proteins allows researchers to explore its biochemical properties, regulatory mechanisms, and interactions with other proteins, providing insights into its role in disease. Utilizing techniques such as bacterial expression systems and mammalian cell culture, scientists can investigate the structure-function relationship of HNF4α, its DNA-binding capability, and its effect on target gene expression. Understanding the functional dynamics of HNF4α through recombinant protein studies can aid in the development of novel strategies for treating metabolic disorders and contribute to the advancement of personalized medicine approaches. As the demand for effective therapeutic interventions rises, the characterization of HNF4α and its signaling pathways remains a vital area of research in metabolic health and disease management.